Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study

International Journal of Epidemiology

Volumn 44, Issue 5, 2015, Pages 1614-1624

  Sekikawa, Akira ^a   Miyamoto, Yoshihiro ^b   Miura, Katsuyuki ^c   Nishimura, Kunihiro ^b   Willcox, Bradley J ^d   Masaki, Kamal H ^d   Rodriguez, Beatriz ^d   Tracy, Russell P ^e   Okamura, Tomonori ^f   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary heart disease; international trend; Japan; risk factors; total cholesterol; Western countries

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR DISEASE; INTERNATIONAL COMPARISON; MORTALITY; RISK FACTOR; STEROL; TREND ANALYSIS; WESTERN WORLD;

ADULT; AGED; ARTICLE; AUSTRALIA; CANADA; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPED COUNTRY; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SPAIN; SWEDEN; TREND STUDY; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FACTUAL DATABASE; GREAT BRITAIN; LIFESTYLE; MIDDLE AGED; MORTALITY; SMOKING;

JAPAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; BLOOD PRESSURE; BODY MASS INDEX; CANADA; CHOLESTEROL; CORONARY DISEASE; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; SPAIN; SWEDEN; UNITED STATES;

EID: 84952907726     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv143     Document Type: Article

References (82)

1. Verschuren WM, Jacobs DR, Bloemberg BP et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries study. JAMA 1995;274:131-36.
2. Hooper L, Summerbell CD, Thompson R et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2011;5:CD002137.
3. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
4. Worth RM, Kato H, Rhoads GG, Kagan K, Syme SL. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol 1975;102:481-90.
5. Yoshiike N, Matsumura Y, Iwaya M, Sugiyama M, Yamaguchi M. National Nutrition Survey in Japan. J Epidemiol 1996;6:S189-200.
6. Farzadfar F, Finucane MM, Danaei G et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3'0 million participants. Lancet 2011;377:578-86.
7. Qiu D, Katanoda K, Marugame T, Sobue T. A joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer 2009;124:443-48.
8. Go AS, Mozaffarian D, Roger VL et al. Heart Disease and Stroke Statistics-2014 Update: A report from the American Heart Association. Circulation 2014; 129:e28-e292.
9. Ikeda N, Saito E, Kondo N et al. What has made the population of Japan healthy? Lancet 2011;378:1094-105.
10. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard. Geneva: World Health Organization, 2001.
11. Danaei G, Finucane MM, Lin JK et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5'4 million participants. Lancet 2011;377:568-77.
12. Finucane MM, Stevens GA, Cowan MJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9'1 million participants. Lancet 2011;377:557-67.
13. Danaei G, Finucane MM, Lu Y et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
14. Ng M, Freeman MK, Fleming TD et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014;311:183-92.
15. Okamura T, Tanaka H, Miyamatsu N et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007;190:216-23.
16. Wakita Asano A, Miyoshi M, Arai Y, Yoshita K, Yamamoto S, Yoshiike N. Association between vegetable intake and dietary quality in Japanese adults: a secondary analysis from the National Health and Nutrition Survey, 2003. J Nutr Sci Vitaminol (Tokyo) 2008;54:384-91.
17. Nakamura M, Sato S, Shimamoto T, Konishi M, Yoshiike N. Establishment of long-term monitoring system for blood chemistry data by the national health and nutrition survey in Japan. J Atheroscler Thromb 2008;15:244-49.
18. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. Hyattsville, MD: U.S. Department Printing Office, 2012.
19. Wijeysundera HC, Machado M, Farahati F et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 2010;303:1841-47.
20. Palmieri L, Bennett K, Giampaoli S, Capewell S. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 2010;100:684-92.
21. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009;30:1046-56.
22. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors?: Evidence from a prospective population-based study. Circulation 2008;117:598-604.
23. Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
24. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 2013;168:934-45.
25. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004;110:1236-44.
26. Ueshima H, Sekikawa A, Miura K et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008;118:2702-09.
27. Sekikawa A, Curb JD, Ueshima H et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008;52:417-24.
28. Saito I, Ozawa H, Aono H, Ikebe T, Yamashita T. [Change of the number of heart disease deaths according to the revision of the death certificates in Oita city]. [Nihon koshu eisei zasshi] Japan J Public Health 1997;44:874-79.
29. Saito I, Aono H, Ikebe T, Ozawa H, Yamashita T. Change in the mortality statistics for heart disease in Japan: an influence of the 10th revision of the International Classification of Diseases. [In Japanese.] Japanese Journal of Cardiovascular Disease Prevention 1998;33:257-65.
30. Hata J, Ninomiya T, Hirakawa Y et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama study (1961-2009). Circulation 2013;128:1198-205.
31. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008;118:2725-29.
32. Sekikawa A, Willcox B, Usui T et al. Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women? J Women's Health 2013;22:966-77.
33. Tanabe N, Iso H, Okada K et al. Serum total and nonhigh-density lipoprotein cholesterol and the risk prediction of cardiovascular events-the JALS-ECC. Circ J 2010;74:1346-56.
34. Teramoto T, Sasaki J, Ishibashi S et al. Absolute risk of cardiovascular disease and lipid management targets. J Atheroscler Thromb 2013;20:689-97.
35. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361, 662 men. Lancet 1986;2:933-36.
36. van den Hoogen PCW, Feskens EJM, Nagelkerke NJD et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 2000;342:1-8.
37. Jacobs DR Jr, Adachi H, Mulder I et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999;159:733-40.
38. NIPPON DATA80 Reserach Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population NIPPON DATA80. Circ J 2006;70:1249-55.
39. Nakamura H, Arakawa K, Itakura H et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006;368:1155-63.
40. Cholesterol Treatment Trialists C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.
41. Ueshima H, Iida M, Shimamoto T et al. High-density lipoprotein-cholesterol levels in Japan. JAMA 1982;247:1985-87.
42. Sekikawa A, Ueshima H, Kadowaki T et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007;165:617-24.
43. Dwyer T, Iwane H, Dean K et al. Differences in HDL cholesterol concentrations in Japanese, American, and Australian children. Circulation 1997;96:2830-36.
44. Ohara K, Klag MJ, Sakai Y, Whelton PK, Itoh I, Comstock GW. Factors associated with high density lipoprotein cholesterol in Japanese and American telephone executives. Am J Epidemiol 1991;134:137-48.
45. Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010;51:2032-57.
46. Toth PP, Barter PJ, Rosenson RS et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol 2013;7:484-525.
47. Teramoto T, Sasaki J, Ishibashi S et al. Diagnostic criteria for dyslipidemia. J Atheroscler Thromb 2013;20:655-60.
48. Kitamura A, Iso H, Naito Y et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994;89:2533-39.
49. Voight BF, Peloso GM, Orho-Melander M et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380:572-80.
50. Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol 2008;2:267-73.
51. Hata Y, Mabuchi H, Saito Y et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002;9:1-27.
52. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-07.
53. Wormser D, Kaptoge S, Di Angelantonio E et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011;377:1085-95.
54. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-45.
55. Fujimoto W. Diabetes in Asian and Pacific Islander Americans. In: Harris M, Cowie CC, Stern M, Boyko E, Reiber G, Bennett P (eds). Diabetes in America. 2nd edn. Bethesda, MD: National Institutes of Health, 1995.
56. Stamler J, Elliott P, Dennis B et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertension 2003;17:591-608.
57. Tudor-Locke C, Johnson WD, Katzmarzyk PT. Accelerometerdetermined steps per day in US adults. Med Sci Sports Exerc 2009;41:1384-91.
58. Ministry of Health Labor and Welfare. Report from the National Health and Nutrition Survey, 2011. (In Japanese.) 2012 http://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/h23-houkoku.pdf (10 July 2015, date last accessed).
59. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med 2009;169:562-71.
60. Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugarsweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010;121:1356-64.
61. US Enviromnetal Protection Aency (EPA). Exposure Factors Handbook: 2011. Washington, DC: National Center for Environmental Assessment, 2011.
62. Stamler J, Elliott P, Chan Q; for the INTERMAP Research Group. Intermap Appendix Tables. J Hum Hypertension 2003;17:665-775.
63. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet. Circulation 2011;123:2870-91.
64. Klein MA, Nahin RL, Messina MJ et al. Guidance from an NIH Workshop on Designing, Implementing, and Reporting Clinical Studies of Soy Interventions. J Nutr 2010;140:S1192-204.
65. Calder PC, Yaqoob P. Marine omega-3 fatty acids and coronary heart disease. Curr Opin Cardiol 2012;27:412-19.
66. Rimbach G, Boesch-Saadatmandi C, Frank J et al. Dietary isoflavones in the prevention of cardiovascular disease-a molecular perspective. Food Chem Toxicol 2008;46:1308-19.
67. Iso H, Kobayashi M, Ishihara J et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006;113:195-202.
68. Kokubo Y, Iso H, Ishihara J et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: The Japan Public Health Center Based (JPHC) Study Cohort I. Circulation 2007;116:2553-62.
69. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-99.
70. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003;77:319-25.
71. Mozaffarian D, Lemaitre RN, King IB et al. Plasma phospholipid long-chain x-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 2013;158:515-25.
72. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians' Health Study: A prospective study. Am J Epidemiol 1995;142:166-75.
73. Yokoyama M, Origasa H, Matsuzaki M et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-98.
74. Kromhout D, Giltay EJ, Geleijnse JM. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010;363:2015-26.
75. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273.
76. The ORIGIN Trial Investigators. n-3 Fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-19.
77. Roncaglioni MC, Tombesi M, Avanzini F et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013;368:1800-08.
78. Sekikawa A, Miura K, Lee S et al. Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. Heart 2014;100:569-73.
79. Sekikawa A, Doyle MF, Kuller LH. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan. Trends Cardiovasc Med 2015;25: 717-23.
80. Susser M. The logic in ecological: II. The logic of design. Am J Public Health 1994;84:830-35.
81. Schwartz S. The fallacy of the ecological fallacy: the potential misuse of a concept and the consequences. Am j Public Health 1994;84:819-24.
82. Susser M. The logic in ecological: I. The logic of analysis. Am J Public Health 1994;84:825-29.